These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice. Foidl BM; Humpel C Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922 [TBL] [Abstract][Full Text] [Related]
3. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease. Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184 [TBL] [Abstract][Full Text] [Related]
4. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171 [TBL] [Abstract][Full Text] [Related]
5. Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease. Chen Y; Tian Z; Liang Z; Sun S; Dai CL; Lee MH; LaFerla FM; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX PLoS One; 2012; 7(12):e51432. PubMed ID: 23236499 [TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Suh YH; Checler F Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532 [TBL] [Abstract][Full Text] [Related]
7. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593 [TBL] [Abstract][Full Text] [Related]
9. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674 [TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Modeling of Alzheimer's Disease. Sasaguri H; Hashimoto S; Watamura N; Sato K; Takamura R; Nagata K; Tsubuki S; Ohshima T; Yoshiki A; Sato K; Kumita W; Sasaki E; Kitazume S; Nilsson P; Winblad B; Saito T; Iwata N; Saido TC Front Neurosci; 2022; 16():807473. PubMed ID: 35431779 [TBL] [Abstract][Full Text] [Related]
11. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868 [TBL] [Abstract][Full Text] [Related]
12. Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models. Hohsfield LA; Daschil N; Orädd G; Strömberg I; Humpel C Mol Cell Neurosci; 2014 Nov; 63():83-95. PubMed ID: 25447943 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Götz J; Schild A; Hoerndli F; Pennanen L Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275 [TBL] [Abstract][Full Text] [Related]
14. Genetics of familial and sporadic Alzheimer's disease. Piaceri I; Nacmias B; Sorbi S Front Biosci (Elite Ed); 2013 Jan; 5(1):167-77. PubMed ID: 23276979 [TBL] [Abstract][Full Text] [Related]
16. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition. Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706 [TBL] [Abstract][Full Text] [Related]
17. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model. Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036 [TBL] [Abstract][Full Text] [Related]
18. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695 [TBL] [Abstract][Full Text] [Related]
19. Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. Galimberti D; Scarpini E Int J Clin Exp Med; 2010 May; 3(2):129-43. PubMed ID: 20607039 [TBL] [Abstract][Full Text] [Related]